Alexion price target raised to $215 from $200 at Brean Capital Brean Capital raised its price target on Alexion following the conclusion of reimbursement discussions in France. The firm raises its estimates on the agreement with the French government and continues to see Alexion as a core holding. Shares are Buy rated.
News For ALXN From The Last 14 Days
Check below for free stories on ALXN the last two weeks.